The Inland Revenue Department said claims from the charity group Oxfam that pharmaceutical companies in New Zealand are underpaying tax by $21 million "completely misrepresents" the situation here.
Inland Revenue international strategy manager John Nash said in a statement the Oxfam report was "clearly incorrect" and relied on flawed methodology.
"Obviously we can't comment on specific taxpayers but taking a global profitability figure and applying it across the board, as this report does, cannot illustrate what's really happening in this country," he said in a statement.
"The report tries to apply a globally derived profit margin figure of 15-16 per cent to New Zealand drug company revenue of $519m and concludes that they have underpaid tax by $21 million," he said.
"This is clearly incorrect given the type of operations that multinational pharmaceutical companies actually undertake in New Zealand," Nash said.